Mirtazapine and Performance status decreased - a phase IV clinical study of FDA data

Summary:

Performance status decreased is reported as a side effect among people who take Mirtazapine (mirtazapine), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Pantoprazole, and have High blood pressure.

The phase IV clinical study analyzes which people have Performance status decreased when taking Mirtazapine. It is created by eHealthMe based on reports of 79,492 people who have side effects when taking Mirtazapine from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Performance status decreased?

Performance status decreased is found to be associated with 514 drugs and 637 conditions by eHealthMe. Check the latest studies of Performance status decreased.

On Aug, 07, 2026

79,492 people reported to have side effects when taking Mirtazapine.
Among them, 29 people (0.04%) have Performance status decreased.

Could Mirtazapine cause Performance status decreased?

Among these 29 people:

How long have people been on Mirtazapine when they have Performance status decreased? *

What is the gender of people who have Performance status decreased when taking Mirtazapine? *

female: 51.85 %
male: 48.15 %

What is the age of people who have Performance status decreased when taking Mirtazapine? *

What are other drugs people take besides Mirtazapine? *

Lyrica: 7 people, 24.14%
Pantoprazole: 7 people, 24.14%
Melatonin: 6 people, 20.69%
Vitamin D2: 6 people, 20.69%
Lioresal: 6 people, 20.69%
Oxycodone And Acetaminophen: 5 people, 17.24%
Metformin: 4 people, 13.79%
Amantadine: 4 people, 13.79%
Sertraline: 3 people, 10.34%
Zolpidem: 3 people, 10.34%

What are other side effects people have besides Performance status decreased? *

Dyspnea (difficult or laboured breathing): 12 people, 41.38%
Fatigue (feeling of tiredness): 8 people, 27.59%
Heart Rate Increased: 6 people, 20.69%
Respiratory Distress (difficulty in breathing): 6 people, 20.69%
Skin Abscess: 6 people, 20.69%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 20.69%
Muscle Spasms (muscle contraction): 6 people, 20.69%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 6 people, 20.69%
High Blood Pressure: 6 people, 20.69%
Oedema Peripheral (superficial swelling): 6 people, 20.69%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 20.69%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 17.24%
Constipation: 4 people, 13.79%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 6.90%
Diabetes: 2 people, 6.90%
Dementia (madness): 2 people, 6.90%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.90%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 6.90%
Fatigue (feeling of tiredness): 2 people, 6.90%
Agitation (state of anxiety or nervous excitement): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and have Performance status decreased?

- Check whether Performance status decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirtazapine:

Mirtazapine (82,120 reports)

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Performance status decreased:

Performance status decreased (514 drugs)

Browse all the conditions that are associated with Performance status decreased:

Performance status decreased (637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Mirtazapine) and Mirtazapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.